Sandra Agudo-Alvarez

Sandra Agudo-Alvarez

Auto-generated profile, based on publicly available information

Sandra Agudo-Alvarez

Instituto de Química Orgánica, Consejo Superior de Investigaciones Científicas (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2024 in Pure and Applied Chemistry
Verified
Journal Article
Open access
SASandra Agudo-Álvarez
Sandra Agudo-Álvarez
SDSandra S. Díaz-Mínguez
Sandra S. Díaz-Mínguez
RBRaúl Benito-Arenas
Raúl Benito-Arenas
The amide bond is one of the most important structural units in nature, as it is part of the backbone of peptides and natural proteins, as well as some essential amino acids, DNA, RNA, hormones, or vitamins found in the body. Furthermore, this bond is significant in the pharmaceutical industry due to its presence in the structure of numerous APIs contained in drugs. This paper reviews the most important methods collected in the bibliography for the preparation of this moiety.

12 November 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
MKMaria Kapanidou
Maria Kapanidou
NCNatalie Curtis
Natalie Curtis
SDSandra S. Diaz-Minguez
Sandra S. Diaz-Minguez
SASandra Agudo-Alvarez
Sandra Agudo-Alvarez
ARAlfredo Rus
Alfredo Rus
Victor M Bolanos-GarciaVictor M Bolanos-Garcia
Victor M Bolanos-Garcia
Activation of the ubiquitin ligase APC/C by the protein Cdc20 is an essential requirement for proper cell division in higher organisms, including humans. APC/C is the ultimate effector of the Spindle Assembly Checkpoint (SAC), the signalling system that monitors the proper attachment of chromosomes to microtubules during cell division. Defects in this process result in genome instability and cancer. Interfering with APC/C substrate ubiquitylation in cancer cells delays mitotic exit, which induces cell death. Therefore, impairing APC/C function represents an opportunity for the treatment of cancer and malignancies associated with SAC dysregulation. In this study, we report a new class of pyrimidinethylcarbamate apcin analogues that interfere with APC/C activity in 2D and 3D breast cancer cells. The new pyrimidinethylcarbamate apcin analogues exhibited higher cytotoxicity than apcin in all breast cancer cell subtypes investigated, with much lower cytotoxicity observed in fibroblasts and RPE-1 cells. Further molecular rationalisation of apcin and its derivatives was conducted using molecular docking studies. These structural modifications selected from the in silico studies provide a rational basis for the development of more potent chemotypes to treat highly aggressive breast cancer and possibly other aggressive tumour types of diverse tissue origins.

Verified
Journal Article
Open access
PDF file
LPLauren Pugh
Lauren Pugh
APAlisha Pancholi
Alisha Pancholi
PPPriscila Celeste Purat
Priscila Celeste Purat
SASandra Agudo-Alvarez
Sandra Agudo-Alvarez
RBRaúl Benito-Arenas
Raúl Benito-Arenas
Victor M Bolanos-GarciaVictor M Bolanos-Garcia
Victor M Bolanos-Garcia
The protein kinase Mps1 (monopolar spindle 1) is an important regulator of the Spindle Assembly Checkpoint (SAC), the evolutionary conserved checkpoint system of higher organisms that monitors the proper bipolar attachment of all chromosomes to the mitotic spindle during cell division. Defects in the catalytic activity and the transcription regulation of Mps1 are associated with genome instability, aneuploidy, and cancer. Moreover, multiple Mps1 missense and frameshift mutations have been reported in a wide range of types of cancer of different tissue origin. Due to these features, Mps1 arises as one promising drug target for cancer therapy. In this contribution, we developed a computational biology approach to study the dynamics of human Mps1 kinase interaction with isoflavones, a class of natural flavonoids, and compared their predicted mode of binding with that observed in the crystal structure of Mps1 in complex with reversine, a small-sized inhibitor of Mps1 and Aurora B kinases. We concluded that isoflavones define a chemical scaffold that can be used to develop new Mps1 inhibitors for the treatment of cancer associated with Mps1 amplification and aberrant chromosome segregation. In a broader context, the present report illustrates how modern chemoinformatics approaches can accelerate drug development in oncology.